Hunan Warrant Pharmaceutical Co., Ltd.SSE: 688799

(688799)"Hunan Warrant Pharmaceutical Co., Ltd."Report for Q3 2026

· Issued by Hunan Warrant Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688799 · · 14 pages · Chinese

Summary by 6ix AI

The report indicates a significant decline in revenue and profit compared to the same period last year, with specific figures provided for total revenue and net profit attributable to shareholders. Additionally, the report outlines various operational updates, including product registrations and ongoing clinical trials for new drugs. The financial statements included in the report have not been audited, and the company has provided assurances regarding the accuracy and completeness of the information presented.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Hunan Warrant Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Warrant Pharmaceutical

All Hunan Warrant Pharmaceutical news releases